Dow Down 0.02% Nasdaq Up 0.07%

Celgene Corporation (CELG)

-NasdaqGS
111.07 Up 0.09(0.08%) 4:00PM EST
|After Hours : 111.07 0.00 (0.00%) 6:43PM EST
Prev Close:110.98
Open:111.24
Bid:110.50 x 100
Ask:N/A
1y Target Est:112.09
Beta:2.02
Next Earnings Date:29-Jan-15CELG Earnings announcement
Day's Range:110.09 - 111.97
52wk Range:66.85 - 111.97
Volume:4,006,238
Avg Vol (3m):4,919,780
Market Cap:88.71B
P/E (ttm):58.18
EPS (ttm):1.91
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Related Video

Headlines

» More Headlines for CELG

Comparison

Symbol% ChgMkt Cap
CELGUp 0.08%88.71B
JNJDown 0.17%298.67B

Key Statistics

Forward P/E (1 yr):22.81
P/S (ttm):12.08
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :3.69
Quarterly EPS Est (Dec-14) :1.00
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):1.18

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies to treat cancer and immune-inflammatory related diseases in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback